Psoriasis patients taking GLP-1 drugs had a 78% lower risk of premature death and a 44% lower risk of heart attack, stroke or other heart-related health crisis, researchers reported Thursday at a meeting of the European Academy of Dermatology and Venereology in Paris
Phase 2a trial of GSBR-1290 (45mg and 90mg) in 54 T2DM patients over 12 weeks observed significant reduction in HbA1c (45 mg: -1.01%, p=0.008
Steady State (~4.3 weeks) The point where drug accumulation stabilizes
Some people experience vivid nightmares or headaches with melatonin, which may compound any dream-related side effects from semaglutide dose escalation
Meanwhile, FDA information on bremelanotide approval
Food and Drug Administration (FDA): Ozempic (semaglutide) Injection Prescribing Information National Institutes of Health (NIH): Gastrointestinal Side Effects of GLP-1 Receptor Agonists and Clinical Management The New England Journal of Medicine (NEJM): Effects of Semaglutide on Chronic Kidney Disease Progression in Patients with Type 2 Diabetes (The FLOW Trial) American Diabetes Association (ADA): Standards of Care in DiabetesMetabolic Strategies and Renal Safety Profile of Incretin-Based Therapies National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Understanding Acute Kidney Injury: Causes, Risks, and Fluid Balance Protocols